# Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes

> **NCT01203592** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 21 (actual)

## Conditions studied

- Congenital Myasthenic Syndrome

## Interventions

- **DRUG:** Albuterol

## Key facts

- **NCT ID:** NCT01203592
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2016-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01203592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01203592, "Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01203592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*